New York cannabis industry - big news! The #OCM has finally announced the release of the #BioTrack API, as well as timelines for Seed to Sale vendor notification. Here’s what you need to know: - Operators must select their Seed-to-Sae provider by January 17 2025, and notify the OCM of their selection here: https://lnkd.in/gYpwUecV - The Seed-to-Sale provider must be capable of integrating with BioTrack At Canix, we’re committed to serving New York operators through this transition. We're already serving a huge portion of the New York market, and we successfully launched BioTrack Florida (the foundation for BioTrack New York). Moreover, we previously transitioned hundreds of customers in Oklahoma to Metrc in 2022. We’ve been through this before, and we provide the specialized inventory conversion uploader - and white glove service - that operators need for a seamless transition. New York - excited to get this moving!
Emles Venture Partners
风险投资与私募股权管理人
New York,New York 536 位关注者
We partner with ambitious founders to build the businesses of tomorrow.
关于我们
We empower founders whose technologies and services positively change society. Emles Venture Partners LLC (“Emles”) is not an investment adviser. The information contained on this website is provided for informational purposes only, and is not intended to be, and does not constitute, investment advice. Such information is general in nature and is not specific to any particular individual’s specific circumstances or needs. Nothing contained on this website constitutes an offer or a solicitation of an offer to buy or sell any security, or a recommendation to purchase, endorsement of, or sponsorship of, any security. Emles is under common ownership with Emles Advisors LLC, an investment advisor registered with the U.S. Securities and Exchange Commission. Emles Advisors LLC is an asset management firm that develops and offers investment products. No investments, investment activities, or performance information of Emles, including any listed on this website, are attributable to Emles Advisors LLC. For important information about Emles Advisors LLC, including its affiliation to Emles, visit www.emles.com.
- 网站
-
https://emlesventure.com/
Emles Venture Partners的外部链接
- 所属行业
- 风险投资与私募股权管理人
- 规模
- 2-10 人
- 总部
- New York,New York
- 类型
- 私人持股
地点
-
主要
437 Madison Avenue
17th Floor
US,New York,New York,10022
Emles Venture Partners员工
动态
-
Very proud of our entire team! This paper is a sneak peek into the exciting work our team is doing in focused ultrasound and non-invasive drug delivery, with more to follow soon. Special congratulations to Zheng Jiang, Michelle Hua, Jacqueline Li, Hieu Le Mau, James Choi, and William Brian Gormley, MD, MPH, MBA.
Excited to share our latest paper published in Bioengineering, covering our latest work in Focused Ultrasound. Please read the full article on the journal:?https://lnkd.in/eqMYPcUB. #focusedultrasound #medtech #surgicalrobotics
-
We’re thrilled to share the news of Shiru’s Series B, as well as plans to expand ProteinDiscovery.ai – our AI-powered discovery platform. This is hot on the heels of being named a TIME Best Invention of 2024. So you might ask what’s ahead? We’re scaling our capabilities to support more partners across food, personal care, and agriculture – bringing natural, high-value ingredients to life faster and more efficiently than ever before. Curious about how AI is disrupting ingredient discovery? Get in touch.
-
?? Zeta Surgical gets FDA 510(k) approval for Zeta navigation system The mixed reality surgical navigation system was already approved in the US for neurosurgery use and was expanded to include enhanced software and compatibility. The current FDA approval expands the AI-powered navigation system’s indication to include use with expanded instruments and enhanced hospital connectivity. It enables the deployment of the Zeta system with different new accessories and surgical kits, including instruments from top medical technology providers, such as IZI Medical. Read more online: https://lnkd.in/epnZWdpw ?? Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing
-
-
Zeta Surgical ?????????? ?????? ??????(??) ?????????????????? ?????? ???????????????????? ???????????? ?? The #FDA has granted #510k clearance to the Zeta #SurgicalNavigation System to expand its indications and compatibility with additional instruments. The #AI-powered system provides high-precision navigation for millions of #neurological procedures, combining #mixedreality and motion-aware remote sensing to offer "#GPS-like" guidance with real-time tracking. The new clearance allows the system to be used with a wider array of surgical accessories and kits, and to integrate into hospital IT networks. COO Hieu Le Mau said, “Our vision is to ensure that advanced #imageguided technology is no longer confined to specialised ORs or surgical suites.?The addition of new surgical kits substantially broadens the system’s applications, opening up new possibilities in neurosurgical procedures, while the enhanced connectivity with hospital systems allows surgeons to easily transfer and access patient information.” It follows the company's announcement of completion of the first multicentre clinical trial examining its Zeta #cranial navigation system, an AI-enabled cranial guidance device designed to be used in #surgery. Congrats Jose Amich and #ZetaSurgical! ?? #medtech #medicaldevice #artificialintelligence #ai #augmentedreality #ar #vr #surgicalnavigation #cranialsurgery #cmf #craniomaxillofacial #neurosurgery #neurology #executivesearch #recruitment #healthtech https://lnkd.in/eZ46J8qf
-
-
This one is especially poignant for me - my first venture investment. When we first chatted, Jose Amich was just starting out, with only a deck that outlined a vision full of limitless opportunities. It was immediately clear that he’s the kind of founder I want to stand behind. Thanks to his hard work, Zeta continues to forge ahead. My appreciation to Pepe and his team.
Zeta Surgical AI-Powered Navigation System Receives FDA Special 510(k) Clearance for Expanded Indications and Instrument Compatibility. Please read full press release below or visit www.zetasurgical.com. #surgery #neurosurgery #medtech #surgicalrobotics
-
Zeta Surgical AI-Powered Navigation System Receives FDA Special 510(k) Clearance for Expanded Indications and Instrument Compatibility. Please read full press release below or visit www.zetasurgical.com. #surgery #neurosurgery #medtech #surgicalrobotics
-
Thrilled to share that Zeta has received its third FDA clearance, which will vastly expand access to our platform across new indications, making it available to countless more patients across the country. Congrats to our entire team and our partners on reaching this milestone!
Zeta Surgical AI-Powered Navigation System Receives FDA Special 510(k) Clearance for Expanded Indications and Instrument Compatibility. Please read full press release below or visit www.zetasurgical.com. #surgery #neurosurgery #medtech #surgicalrobotics
-
?? A special thank you to Lenka Roz Schanova for producing and hosting the ?eská investi?ní konference on November 11th in Prague. As I prepare for this event, I’m looking forward to sharing insights on our investment process, the private and public market landscapes as we head into 2025, and examples of investments we are actively monitoring. I invite fellow attendees and anyone interested in these topics to connect with me at the conference or reach out directly. Let’s discuss how we can leverage insights together! #InvestmentStrategy #MacroOutlook #PublicMarkets #PrivateMarkets #Equities #PrivateEquity #VentureCapital #Investing #ThoughtLeadership
?? Do ?eská investi?ní konference zbyvá posledních pár dní! Tě?it se m??ete na 26 ?pi?kovych investi?ních profesionál?, 6 inspirativních p?edná?ek a témě? 40 mastermindovych skupin plnych zku?eností a know-how. V dopoledním programu vás ?ekají skvělé p?edná?ky od Michal ?nobr, Bronislav Kandrik, Jan Ruzicka, Emanuel Zareh, Branislav Soták, a Abie Shamah, v odpoledním programu poté mastermindové skupiny. Nenechte si ujít p?íle?itost na?erpat nové nápady a pohledy, které vás mohou posunout v investování dál. ?? ?eská investi?ní konference, ji? 11. 11. v Hotelu Pyramida: https://lnkd.in/gxSG7c7
-
-
?? Exciting News from Emles Venture Partners! ?? We’re thrilled to spotlight our Head of Investments, Emanuel Zareh, in a recent interview where he shares his unique insights into special situation investing. With a rich background spanning Morgan Stanley, the National Football League (NFL) and leading hedge funds, Emanuel is redefining investment strategies. Don’t miss his upcoming mastermind group at the Czech Investment Conference on November 11th in Prague, where he’ll delve into effective tactics for today’s market. ?? Catch the full interview here: https://lnkd.in/eAzmuvb ?? Learn more about the upcoming Czech Investment Conference: https://lnkd.in/eTctiYE #Investing #Finance #SpecialSituations #CzechInvestmentConference #EmlesVenturePartners #Venture #Equities #HedgeFunds #Alternatives
? SPECIAL INVESTMENT SITUATIONS ? In this insightful interview, Emanuel Zareh, SVP of Investments at Emles Advisors LLC, shares his journey in the world of finance, starting from his early days at Morgan Stanley through to his current role. With a robust background that spans a diverse range of industries, including the NFL and top-tier hedge funds like Andor Capital, Emanuel has cultivated a unique approach to special situation investments. He discusses his perspective on global investment opportunities, with insights into the potential and challenges of investing in China and thoughts on exploring markets in Central Europe, such as the Czech Republic. Emanuel dives into real-world examples of special situation investments, with a focus on his strategic approach to this complex area of finance. Notably, he shares his views on companies like Groupon and emerging industries he believes hold promise for the future. Attendees of the Czech Investment Conference will have the opportunity to hear more from Emanuel as he leads a mastermind group, discussing his expertise in special situations and investment tactics in today’s market. After completing his BA at Colgate University in 2001, Mr. Zareh began his career in M&A at Morgan Stanley before contributing his skills to the NFL and later earning an MBA from Harvard Business School. With experience at firms like Clovis Capital, Sandler Capital, Hutchin Hill Capital, and Bayfield Court Capital Management, Mr. Zareh has developed a well-rounded view on investment opportunities across different market structures, making this a conversation rich with insight for investors and finance enthusiasts alike. ?? Listen to the full interview: https://lnkd.in/eAzmuvbt ?? More about the Czech Investment Conference: https://lnkd.in/eTctiYE